Filing Details

Accession Number:
0001799191-22-000058
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-20 20:07:11
Reporting Period:
2022-12-16
Accepted Time:
2022-12-20 20:07:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1799191 Oncology Institute Inc. TOI Services-Offices & Clinics Of Doctors Of Medicine (8011) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1915822 P Matthew Miller C/O The Oncology Institute Inc.
18000 Studebaker Rd, Suite 800
Cerritos CA 90703
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-16 73,684 $0.95 175,325 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 577 shares, with the reporting persons sale of shares of common stock on November 15, 2022. The reporting person has paid to the Issuer the full amount of the profit realized in connection with the short-swing transaction, less transaction costs, calculated in accordance with Section 16(b).